PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-05-30

Date Title Company
30-May-2020 MimiVax Phase 2 study of SurVaxM in combination with pembrolizumab opens for recurrent glioblastoma patients MimiVax LLC
30-May-2020 Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients Guardant Health AMEA
30-May-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
30-May-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration